Current studentsExisting staffContact us
 

A comparative analysis of the Libyan national essential medicines list and the WHO model list of essential medicines

Simple item page
dc.contributor.authorMustafa, A.A.
dc.contributor.authorKowalski, S.R.
dc.date.issued2010
dc.description.abstractAim and Objectives: To examine the concordance of the Libyan Pharmaceutical List of Essential Medicines (LPLEM) with the World Health Organization Model List of Essential Medicines 2009 (WMLEM 2009). Methods: The concordance between generic medicines listed in the WMLEM 2009 (standard reference list) and the LPLEM 2006 (comparator list) was evaluated. Results: The total number of Basic Essential Medicines (BEMs) listed on the WMLEM 2009 was 347. The total number of generic medicines listed on the LPLEM was 584. Although the LPLEM has more listed medicines, only 270 (77.6%) of BEMs from the WMLEM were listed as available. However, 25 of the 77 missing medicines were deemed to have appropriate alternatives. A total of 52 medicines from the WMLEM 2009 were therefore missing from the LPLEM. Discrepancies compared to the WMLEM 2009 were identified in 15 out of 29 therapeutic sections. The highest discrepancy rate from the WMLEM 2009 was in the anti-infective section (35 missing medicines). Missing BEMs were noted in many subclassifications of the antiinfective medicines section, but omissions were particularly prevalent in the antibacterial medicines subsection (11 missing medicines). Antituberculosis medications had the highest discrepancy rate for antibacterial BEMs with one-third of the single medicines recommended by the WHO in the WMLEM 2009 not listed on the LPLEM. Of the 314 additional medicines on the LPLEM, 18 were deemed to be irrational non-essential medicines. Conclusion: The LPLEM does not include several essential medicines recommended by the WHO in the WMLEM 2009. These discrepancies may have serious public health implications for management of some infectious diseases, particularly, tuberculosis and HIV.
dc.identifier.citationLibyan Journal of Medicine, 2010; 5(1):1-9
dc.identifier.doi10.3402/ljm.v5i0.5403
dc.identifier.issn1993-2820
dc.identifier.issn1819-6357
dc.identifier.urihttps://hdl.handle.net/1959.8/118223
dc.language.isoen
dc.publisherTaylor & Francis
dc.rightsCopyright 2010 Asma Abubakr Mustafa and Stefan Robert Kowalski. This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. (http://creativecommons.org/licenses/by-nc/3.0/)
dc.source.urihttps://doi.org/10.3402/ljm.v5i0.5403
dc.subjectessential medicines
dc.subjectmedicine selection
dc.subjectnational medicines policy
dc.subjectpharmaceuticals
dc.titleA comparative analysis of the Libyan national essential medicines list and the WHO model list of essential medicines
dc.typeJournal article
pubs.publication-statusPublished
ror.fileinfo12143268720001831 13143266600001831 9915910542901831_53108830740001831.pdf
ror.mmsid9915910542901831

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
9915910542901831_53108830740001831.pdf
Size:
232.28 KB
Format:
Adobe Portable Document Format
Description:
Published version
Download

Collections